Dong-A Pharmaceutical announced on the 16th that Gumguard, its specialized gum care brand, surpassed 10.3 billion KRW in annual sales last year.


Donga Pharmaceutical Gum Care Brand 'Geomguard' <br>[Photo by Donga Pharmaceutical]

Donga Pharmaceutical Gum Care Brand 'Geomguard'
[Photo by Donga Pharmaceutical]

View original image

Gumguard, a specialized gum care brand that helps manage periodontal diseases such as gingivitis and periodontitis, has continued to achieve steady sales growth since its relaunch in 2020. Following 1.6 billion KRW in 2021 and 4 billion KRW in 2022, last year's sales reached 10.3 billion KRW, marking a 157% increase and recording triple-digit growth rates for two consecutive years.


The oral rinse Gumguard Original applies a patented complex of five key ingredients that are excellent for gum health. The main components include potassium glycyrrhizinate, which helps improve gum inflammation; cetylpyridinium chloride hydrate, which eliminates bacteria causing gum disease; sodium monofluorophosphate for cavity prevention; tocopheryl acetate, effective for gum protection; and panthenol. Notably, a clinical study conducted with Yonsei University College of Dentistry confirmed that after six weeks of use, gum inflammation index decreased by 50.9% and bleeding frequency by 56.9%. In addition, Gumguard offers a multi-faceted gum care solution by launching Gumguard toothpaste, which helps manage tooth sensitivity and gum inflammation.



A Dong-A Pharmaceutical representative stated, "We will continue our relentless research on consumer demands such as gum disease care and post-implant management to establish Gumguard as the leading brand in gum care."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing